T

Tempest

25 employees

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

Basic info

Industry

biotechnology research

Sectors

Immuno-oncology
Biotechnology
Therapeutics
Health Care

Date founded

2011

Funding rounds raised

Total raised

$70M

from 6 investors over 6 rounds

T

Tempest raised $15M on April 27, 2022

Investors: Versant Ventures

T

Tempest raised $70M on March 28, 2018

Investors: Lilly Asia Ventures, F-Prime Capital Partners, Quan Capital 泉创资本, Foresite Capital and Versant Ventures

FAQ